Spotlight
Deep Tech Spinouts: Inside AlbionVC’s Decade-Long Partnership with UCL | Dave Grimm
AlbionVC Partner Dave Grimm shares how a decade-long partnership with UCL is rewriting the rules for academic entrepreneurship
Can AI data pains lead to photonics business opportunities? | BI Foresight
AlbionVC partner Dave Grimm on why now is the time for photonics chips to shine
AlbionVC: London still outpaces Paris in tech | UKTN
Ed Lascelles, AlbionVC Partner shares insights on the State of European Tech: Why London Still Leads
Universities should not be greedy with technology spin-offs | FT
Dave Grimm, Partner at AlbionVC, chats to John Gapper, Financial Times, on the opportunities that commercialising research presents, on the back of our very successful partnership with UCL.
UK universities take record low spinout stakes: ‘But that’s only half the battle’
David Grimm, Partner AlbionVC discusses university spinout terms and timelines with Sifted
The outlook for venture capital & tech in 2024
Christoph Ruedig on the BVCA 40th Anniversary Podcast Series
Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT
UCLTF cell therapy startup Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT
Leigh Brody, UCLTF Investor | Career in Discovery Podcast
Leigh Brody, UCLTF investor on TalentSingular’s ‘Careers in discovery’ podcast
Bramble Energy among 23 deeptech startups primed to take off | Business Insider
Bramble Energy | Business Insider